|
|
Volumn 5, Issue 1, 2002, Pages 4-11
|
|
Drug development: A perspective from Africa
|
|
Author keywords
Africa; Drug development; Tropical diseases
|
|
Indexed keywords
AMINOSALICYLIC ACID;
ANTIFILARIAL AGENT;
ANTIINFECTIVE AGENT;
ANTIMALARIAL AGENT;
ANTIPARASITIC AGENT;
ANTIRETROVIRUS AGENT;
ANTITRYPANOSOMAL AGENT;
ARTEETHER;
ARTEMISININ DERIVATIVE;
ATOVAQUONE PLUS PROGUANIL;
CHLOROQUINE;
CYCLOSERINE;
DIETHYLCARBAMAZINE;
EFLORNITHINE;
ETHAMBUTOL;
ETHIONAMIDE;
HALOFANTRINE;
ISONIAZID;
MEFLOQUINE;
MELARSOPROL;
PENTAMIDINE;
PRIMAQUINE;
PROGUANIL;
PYRAZINAMIDE;
QUININE;
RIFAMPICIN;
STREPTOMYCIN;
SURAMIN;
TUBERCULOSTATIC AGENT;
UNINDEXED DRUG;
AFRICA;
ARMY;
BUDGET;
DEATH;
DEVELOPING COUNTRY;
DRUG COST;
DRUG INDUCED DISEASE;
DRUG INDUSTRY;
DRUG RESEARCH;
FILARIASIS;
HEALTH CARE FINANCING;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HISTORY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION;
INTERNATIONAL COOPERATION;
MALARIA;
MORALITY;
PARASITOSIS;
POVERTY;
REVIEW;
SOCIAL ASPECT;
SOLDIER;
TRYPANOSOMIASIS;
TUBERCULOSIS;
WAR;
|
|
EID: 0036351065
PISSN: 14630095
EISSN: None
Source Type: Journal
DOI: 10.1185/146300902322125091 Document Type: Review |
|
Times cited : (6)
|
|
References (30)
|
